Use of COPRAS decision model for the selection of best treatment alternatives in removing micropollutants: Diclofenac example
Küçük Resim Yok
Tarih
2025
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Elsevier Ltd
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Diclofenac (DCF) is one of nonsteroidal anti-inflammatory drugs that is not effectively removed in drinking water and wastewater treatment plants. In recent times, DCF has been found in many drinking water sources, highlighting the increasing need to enhance current wastewater and drinking water treatment facilities through advanced treatment technologies to efficiently eliminate DCF and other micropollutants. Nonetheless, selecting the best treatment technologies is a complex matter in this modernization process, requiring multidimensional thinking and multi-criteria decision-making. This study introduces a new approach with defined multi-dimensional evaluation criteria and a multi-criteria decision-making method for choosing the best treatment alternatives and technologies. This new approach was applied and tested to determine the best treatment alternatives for DCF, one of the emerging micropollutants in this study. In this context, a total of 18 evaluation criteria were determined and prioritized. A thorough literature review was conducted to identify and assess the performance of the treatment alternatives. In determining these alternatives, the “complex proportional assessment (COPRAS)” analytical decision-making method was used in the decision-making process and their priority rankings were determined. The final priority order was determined as membrane filtration > adsorption > hybrid processes > advanced oxidation processes > artificial wetlands > oxidation processes > conventional treatment processes > biological treatment > other treatment processes. Membrane processes were discovered to be the most effective tertiary treatment alternative for DCF removal. If membrane processes are preferred as tertiary treatment in a treatment plant, the application of concentrated management techniques such as volume reduction will further increase the environmental benefit. © 2025 Elsevier B.V., All rights reserved.
Açıklama
Anahtar Kelimeler
Complex Proportional Assessment (copras), Diclofenac (dcf), Drinking Water, Wastewater, Diclofenac, Anti-inflammatory Agents, Non-steroidal, Diclofenac, Drinking Water, Wastewater, Water Pollutants, Chemical, Biofiltration, Biological Membranes, Decision Making, Membrane Technology, Microfiltration, Wastewater Treatment, Water Filtration, Complex Proportional Assessment, Complex Proportional Assessments, Diclofenac, Evaluation Criteria, Membrane Process, Micropollutants, New Approaches, Treatment Process, Treatment Technologies, Biological Water Treatment, Diclofenac, Drinking Water, Nonsteroid Antiinflammatory Agent, Adsorption, Chemical Pollutant, Concentration (composition), Drug, Filtration, Oxidation, Pollutant Removal, Wastewater Treatment Plant, Wetland, Article, Constructed Wetland, Decision Model, Economic Aspect, Multicriteria Decision Analysis, Pollutant, Reduction (chemistry), Safety, Waste Water Treatment Plant, Wastewater, Water Loss, Water Treatment, Chemistry, Decision Making, Procedures, Sewage, Water Management, Water Pollutant, Adsorption, Anti-inflammatory Agents, Non-steroidal, Decision Making, Drinking Water, Filtration, Waste Disposal, Fluid, Wastewater, Water Pollutants, Chemical, Water Purification, Wetlands
Kaynak
Chemosphere
WoS Q Değeri
Scopus Q Değeri
Q1
Cilt
375
